Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13‐valent pneumococcal conjugate vaccine era

The aim was to analyze the epidemiological, microbiological and clinical characteristics of patients with complicated pneumococcal pneumonia with pleural effusion (PE) or empyema.

[1]  M. Garcés-Sánchez,et al.  [Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations]. , 2020, Anales de pediatria.

[2]  M. Ramirez,et al.  Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015 , 2018, Emerging infectious diseases.

[3]  J. Picazo,et al.  Effects of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Infants Aged 0 to 90 Days in Madrid, Spain. , 2018, Journal of the Pediatric Infectious Diseases Society.

[4]  N. Andrews,et al.  Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. , 2018, The Lancet. Infectious diseases.

[5]  L. Valinsky,et al.  Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel , 2018, Emerging infectious diseases.

[6]  C. Muñoz-Almagro,et al.  Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study , 2017, PloS one.

[7]  M. Garcés-Sánchez,et al.  Immunisation schedule of the Spanish Association of Paediatrics: 2019 recommendations , 2019, Anales de Pediatría (English Edition).

[8]  Yuwei Zhu,et al.  Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. , 2016, Vaccine.

[9]  K. Fuursted,et al.  The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination , 2016, Heliyon.

[10]  M. Rose,et al.  Therapy of 645 children with parapneumonic effusion and empyema—A German nationwide surveillance study , 2016, Pediatric pulmonology.

[11]  K. Vassiou,et al.  Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine , 2016, Infectious diseases.

[12]  C. Muñoz-Almagro,et al.  Invasive pneumococcal disease rates linked to meteorological factors and respiratory virus circulation (Catalonia, 2006–2012) , 2016, BMC Public Health.

[13]  C. Muñoz-Almagro,et al.  Vaccine Failures in Patients Properly Vaccinated with 13-Valent Pneumococcal Conjugate Vaccine in Catalonia, a Region with Low Vaccination Coverage , 2016, The Pediatric infectious disease journal.

[14]  H. Schmitt,et al.  Pneumococcal serotype evolution in Western Europe , 2015, BMC Infectious Diseases.

[15]  S. Kaplan,et al.  Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. Pirçon,et al.  Epidemiology of invasive pneumococcal disease in Saudi Arabian children younger than 5 years of age , 2015, Journal of epidemiology and global health.

[17]  C. Romero,et al.  Changes in Hospitalizations for Pneumonia After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13 Valent and Haemophilus influenzae Type b Conjugate Vaccine in a Pediatric Referral Hospital in Uruguay , 2014, The Pediatric infectious disease journal.

[18]  R. Cohen,et al.  Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  G. Tzanakaki,et al.  Parapneumonic Pleural Effusions Caused by Streptococcus pneumoniae Serotype 3 in Children Immunized with 13-Valent Conjugated Pneumococcal Vaccine , 2014, The Pediatric infectious disease journal.

[20]  P. Brotons,et al.  Rapid and Easy Identification of Capsular Serotypes of Streptococcus pneumoniae by Use of Fragment Analysis by Automated Fluorescence-Based Capillary Electrophoresis , 2012, Journal of Clinical Microbiology.

[21]  P. Bahri,et al.  The concept of vaccination failure. , 2012, Vaccine.

[22]  John S. Bradley,et al.  The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  I. Balfour-Lynn,et al.  Increased incidence of bronchopulmonary fistulas complicating pediatric pneumonia , 2011, Pediatric pulmonology.

[24]  E. Emini,et al.  Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age: A Double-blind Randomized Active-controlled Trial , 2010, The Pediatric infectious disease journal.

[25]  E. Emini,et al.  Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers , 2010, Pediatrics.

[26]  L. Hoffman,et al.  Management of children with empyema: Pleural drainage is not always necessary , 2010, Pediatric pulmonology.

[27]  C. Luaces,et al.  Pediatric parapneumonic pleural effusion: Epidemiology, clinical characteristics, and microbiological diagnosis , 2009, Pediatric pulmonology.

[28]  C. Muñoz-Almagro,et al.  Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  C. Muñoz-Almagro,et al.  Pediatric Parapneumonic Empyema, Spain , 2008, Emerging infectious diseases.

[30]  C. Muñoz-Almagro,et al.  Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  I. Jado,et al.  Dot blot assay for the serotyping of pneumococci , 1997, Journal of clinical microbiology.

[32]  W. Kröger,et al.  Recommendations , 1915, Nature.